Vulvar lichen sclerosus: modern approaches to diagnosis and treatment

• Anna V. Borisova
• Olga I. Klimova
• Natalia N. Valentinova

Abstract

The problem of vulvar lichen sclerosus remains a little-studied area in gynecology. There is no single generally accepted theory of the pathogenesis of this disease, as well as a clear algorithm for treating patients. For a long time, this pathology was considered the prerogative of menopausal and postmenopausal women, but over the past decades, there has been a trend of its “rejuvenation”. At the same time, the high risk of malignancy of vulvar lichen sclerosus, which ranges from 10 to 35%, is of great concern. This review presents current data on the pathogenesis, diagnosis and treatment of vulvar lichen sclerosus, which will be useful both for obstetrician-gynecologists and for doctors of related specialties.

Keywords:vulvar lichen sclerosus; diagnosis; treatment; pathogenesis

REFERENCES

1. Nair P.A. Vulvar lichen sclerosus et atrophicus. J Midlife Health. 2017; 8 (2): 55–62. DOI: 10.4103/jmh.JMH_13_17

2. Semenchak Yu.А., Snarskaya E.S. Scleroatrophic lichen. Vrach [Physician]. 2018; (8): 26–34. (in Russian)

3. Singh N., Ghatage P. Etiology, clinical features, and diagnosis of vulvar lichen sclerosus: a scoping review. Obstet Gynecol Int. 2020:748–54. DOI: 10.1155/2020/7480754

4. Semenchak Yu.A. Scleroatrophic lichen – current data on the etiology, pathogenesis, clinical features and treatment. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney [Russian Journal of Skin and Venereal Diseases]. 2019; 22 (3–4): 73–85. (in Russian)

5. Wilkinson E., Stone I. Diseases of the vulva: A clinical guide. Transl. from Engl. Moscow: BINOM, 2009: 248 p. (in Russian)

6. Kreuter A., Kryvosheyeva Y., Terras S., et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm Venereol. 2013; 93: 238–41.

7. Birenbaum D.L., Young R.C. High prevalence of thyroid disease in patients with lichen sclerosus. J Reprod Med. 2007; 52: 28–30.

8. Tran D.A., Tan X., Macri C.J., et al. Lichen Sclerosus: an autoimmunopathogenic and genomic enigma with emerging genetic and immune targets. Int J Biol Sci. 2019; 15 (7): 1429–39. DOI: 10.7150/ijbs.34613

9. Utsunomiya N., Utsunomiya A., Chino T., et al. Gene silencing of extracellular matrix protein 1 (ECM1) 
results in phenotypic alterations of dermal fibroblasts reminiscent of clinical features of lichen sclerosus. J. Dermatol. Sci. 2020; 100: 99–109.

10. Günthert A.R., Faber M., Knappe G. et al. Early onset vulvar lichen sclerosus in premenopausal women and oral contraceptives. Eur J Obstet Gynecol Reprod Biol. 2008;137: 56–60.

11. Marfatia Y., Surani A., Baxi R. Genital lichen sclerosus et atrophicus in females: an update. Indian J Sex Transm Dis AIDS. 2019; 40 (1): 6–12. DOI: 10.4103/ijstd.IJSTD_23_19

12. Aide S., Lattario F.R., Almeida G., et al. Epstein-Barr virus and human papillomavirus infection in vulvar lichen sclerosus. J Low Genit Tract Dis. 2010; 14 (4): 319–22.

13. Nasca M.R., Lacarrubba F., Micali G. Human papillomavirus infection and lichen sclerosus: coincidence or link? Int J Dermatol. 2018; 57: 611–24.

14. Oyama N. Current Understanding of Molecular-based Immunopathology in Lichen Sclerosus. International Trends in Immunity. 2015: 6.

15. Dvornikov A.S. Treatment of localized scleroderma with hyaluronidase. Vestnik dermatologii and venerologii [Bulletin of Dermatology and Venereology]. 2013; (3): 96–100. DOI: https://doi.org/10.25208/vdv627 (in Russian)

16. Paulis G., Berardesca E. Lichen sclerosus: the role of oxidative stress in the pathogenesis of the disease and its possible transformation into carcinoma. Res Rep Urol. 2019; 20 (11): 223–32. DOI: 10.2147/RRU.S205184

17. Basheer S., Shameena P.M., Sudha S., et al. Expression of survivin and p53 in oral lichen planus, lichenoid reaction and lichenoid dysplasia: An immunohistochemical study. J Oral Maxillofac Pathol. 2017; 21 (3): 456–7. DOI: 10.4103/jomfp.JOMFP_39_15

18. Batyrovа Z.K., Uvarova E.V., Kolodkina A.A., Latypova N.Kh Some aspects of diagnosis and choice of treatment measurement of children with vulvar lichen sclerosus

Reproduktivnoe zdorov’e detey detey i podrostkov [Pediatric and Adolescent Reproductive Health]. 2016; 5: 34–8. (in Russian)

19. Fruchter R., Melnick L., Pomeranz M.K. Lichenoid vulvar disease: a review. Int J Womens Dermatol. 2017; 3 (1): 58–64. DOI: 10.1016/j.ijwd.2017.02.017

20. Berger M.B., Damico N.J., Menees S.B. et al. Rates of self-reported urinary, gastrointestinal, and pain comorbidities in women with vulvar lichen sclerosus. J Low Genit Tract. 2012;16 (3): 285–9.

21. Kirtschig G. Lichen Sclerosus-Presentation, Diagnosis and Management. 2016; 113 (19): 337–43. DOI: 10.3238/arztebl.2016.0337

22. Khaitan B.K. In: Nonvenreal diseases of genitalia. Sexually Transmitted Diseases and AIDS. 1^st ed. Sharma VK, New Delhi: Viva Books Pvt. Ltd. 2003. Р. 413–21.

23. Bornstein J.
Vulvar Disease: Breaking the Myths. 2019. DOI: 10.1007/978-3-319-61621-6


24. Lacarrubba F., Pellacani G., Verzì A.E., et al. Extragenital lichen sclerosus: Clinical, dermoscopic, confocal microscopy and histologic correlations. J Am Acad Dermatol. 2015; 72 (1): 50–2.

25. Rakislova N., Alemany L., Clavero O., et al. p53 Immunohistochemical patterns in hpv-independent squamous cell carcinomas of the vulva and the associated skin lesions: a study of 779 cases. Int J Mol Sci. 2020; 21: 8091. DOI: https://doi.org/10.3390/ijms21218091

26. Corazza M., Borghi A., Minghetti S., et al. Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: Results from a comparative trial. J Eur Acad Dermatol Venereol (JEADV). 2016; 30 (6): 956–61. DOI: https://doi.org/10.1111/jdv.13166 PMID: 25904498.

27. Sokolova A.V., Apolikhina I.A. Treatment for female external genital lichen sclerosus: from standards to innovations. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2020; (7): 37–46. (in Russian). URL: https://dx.doi.org/10.18565/aig.2020.7.37-46 (in Russian)

28. Oikarinen A. Systemic estrogens have no conclusive beneficial effect on human skin connective tissue. Acta Obstet Gynecol Scand. 2009; 79 (4): 250–4. DOI: https://doi.org/10.1080/j.1600-0412.2000.079004250.x

29. Clinical recommendations «Sclerotic and atrophic lichen». In: All-Russian public organization «Russian Society of Dermatovenereologists and Cosmetologists». Moscow, 2020. (in Russian)

30. Hennge U.R. Lichen sclerosus. In: K. Wolf, L.A. Goldmit, S.I. Katz, et al. (eds); Transl. from Engl.; Gen. ed. A.A. Kubanova. Fitzpatrick’s Dermatology in Clinical Practice: In 3 vols. Moscow: Izdatel’stvo Panfilova; BINOM. Laboratoriya znaniy, 2012; (1): 598–602. (in Russian)

31. Krapf J.M., Mitchell L., Holton M.A., et al. Vulvar lichen sclerosus: current perspectives. Int J Womens Health. 2020; 12: 11–20. DOI: https://doi.org/10.2147/IJWH.S191200

32. Karabut М.М., Gladkova N.D., Fel’dshteyn F.I. Fractional laser photothermolysis in the treatment of skin defects: possibilities and effectiveness (review). Sovremennye tekhnologii v meditsine [Modern Technologies in Medicine]. 2016; 8 (2): 98–108. DOI: https://doi.org/10.17691/stm2016.8.2.14 (in Russian)

33. Apolikhina I.A., Sokolova A.V., Balashov I.S., Chernukha L.V., Ermakova E.I. Treatment vulvar lichen sclerosus with fractional CO2-laser: cohort clinical study. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie [Obstetrics and Gynecology: News, Opinions, Training]. 2020; 8 (2): С. 48–58. DOI: https://doi.org/10.24411/2303-9698-2020-12004 (in Russian)

34. Tan Q., Li J., Yin Y. The role of growth factors in the repair of motor injury. Front Pharmacol. 2022; 19 (13): 898152. DOI: https://doi.org/10.3389/fphar.2022.898152

35. Turzi Antoine & REGEN LAB Team. Biobridge Foundation Editions. PRP Standardisation & Cells Therapies. Lausanne, Switzerland, 2018: 96 p.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)